Repository

• Home
• Repository
• Publications

Publications

Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study Rimini M, Fornaro L, Prinzi FL, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Salani F, De Rosa A, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Corallo S, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Vitiello F, Himmelsbach V, Landriscina M, Djaballah SA, Tesini G, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A. Int J Cancer. 2025 May 19. doi: 10.1002/ijc.35481. 2025

Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques Singh Y, Andersen JB, Hathaway Q, Venkatesh SK, Gores GJ, Erickson B Oncotarget. 2025 Apr 4;16:249-255. doi: 10.18632/oncotarget.28709 2025  Results from

New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas Olaizola I, Odriozola-Gimeno M, Olaizola P, Caballero-Camino FJ, Pastor-Toyos N, Tena-Garitaonandia M, Lapitz A, Val B, Guimaraes AR, Asensio M, Huici-Izagirre M, Rae C, de Sancho D, Lopez X, Rodrigues PM, Herraez E, Briz O, Izquierdo-Sanchez L, Eleta-Lopez A, Bittner AM, Martinez-Amesti A, Miranda T, Ilyas SI, Braconi C, Perugorria MJ, Bujanda L, Rivilla I, Marin JJG, Cossio FP, Banales JM J Hepatol. 2025 May 3:S0168-8278(25)00293-4. doi: 10.1016/j.jhep.2025.04.034 2025

Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysis Akkus E, Yasar HA, Rimassa L, Lamarca A Target Oncol. 2025 Apr 13. doi: 10.1007/s11523-025-01142-8 2025  Funded by

Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials Yoo C, Saborowski A, Hyung J, Wenzel P, Kim I, Wege H, Kim K, Folprecht G, Ryoo B, Schütt P, Cheon J, Götze T, Ryu H, Lee J, Vogel A Journal of Hepatology. 2025 Mar 25. doi: 10.1016/j.jhep.2025.03.013 2025